Position in ABBV
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$519,636
+$70,520 QoQ
Shares Held
2,065
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#3,119
of 4,153 holders
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NORTHSTAR ASSET MANAGEMENT Co holds $10,204,107 across 8 Drug Manufacturers - General names. ABBV ranks #6 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
18,776 | $4,768,540 | |
| 2 | NVS |
Novartis AG
|
13,875 | $2,174,490 | |
| 3 | NVO |
Novo Nordisk A S
|
18,853 | $903,812 | |
| 4 | MRK |
Merck & Co., Inc.
|
6,130 | $787,705 | |
| 5 | LLY |
ELI LILLY & Co
|
617 | $740,048 | |
| 6 | ABBV |
AbbVie Inc.
This page
|
2,065 | $519,636 | |
| 7 | PFE |
Pfizer Inc
|
11,074 | $266,661 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
750 | $43,215 |
All Filings in ABBV
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $519,636 | 2,065 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $449,116 | 2,065 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $483,256 | 2,115 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $489,707 | 2,115 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $392,586 | 2,115 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $448,372 | 2,140 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $380,278 | 2,140 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $422,607 | 2,140 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $367,052 | 2,140 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $432,487 | 2,375 | Shares | Sole | 2024-04-26 | |
| 2023-12-31 | $368,053 | 2,375 | Shares | Sole | 2024-01-29 | |
| 2023-09-30 | $354,017 | 2,375 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $293,037 | 2,175 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $345,036 | 2,165 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $347,461 | 2,150 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $288,551 | 2,150 | Shares | Sole | 2022-10-19 | |
| 2022-06-30 | $329,294 | 2,150 | Shares | Sole | 2022-07-20 | |
| 2022-03-31 | $348,536 | 2,150 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $291,110 | 2,150 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $231,920 | 2,150 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $242,176 | 2,150 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $232,240 | 2,146 | Shares | Sole | 2021-04-21 | |
| 2020-12-31 | $257,267 | 2,401 | Shares | Sole | 2021-01-21 | |
| 2020-06-30 | $233,275 | 2,376 | Shares | Sole | 2020-08-03 | |
| No filing history on record for this holder in this stock. | ||||||